Keywords:
comorbidity, chronic heart failure, myocarditis, vasoconstrictor systems, vasodilator systems.References
1. Arutyunov A.G., Dragunov D.O., Arutyunov G.P. et al. The First Open Study of the Syndrome of Acute Decompensated Heart Failure and Comorbid Diseases in the Russian Federation: The ORAKUL-RF Independent Registry. Kardiologiya. 2015;55(5):12–21.
2. Astrakhantseva Yu.S., Krasnikova N.V. Implementation of the National Recommendations of the Russian Society of Cardiology, Russian Society of Cardiology and Russian National Society of Internal Medicine on the Diagnosis and Treatment of Chronic Heart Failure (4th Revision): Correspondence of Statistical Data on Etiology, Clinical Course, and Staging with Real-World Clinical Practice Based on Outpatient Patients. Saratov Journal of Medical Scientific Research. 2016;(2):169–174.
3. Beilina N.I., Pozdnyak A.O. Comorbidity of Patients in a Therapeutic Inpatient Department. PM. 2018;(9):6–10.
4. Bobozhonov S.S. Characteristics of Comorbidity in Cardiac Patients in a Multidisciplinary Hospital. Economics and Society. 2021;1-1(80):381–385.
5. Vatutin N.T., Smirnova A.S., Gasendich E.S. Specific Features of Examination and Treatment of Patients with Chronic Heart Failure and Concomitant Chronic Obstructive Pulmonary Disease. Clinical Medicine. 2017;(6):444–450.
6. Vatutin N.T., Shevelyok A.N. The Effect of Comorbid Conditions on Blood Aldosterone Levels in Patients with Chronic Heart Failure and Preserved Left Ventricular Systolic Function. Cardiovascular Therapy and Prevention. 2017;(6):34–38.
7. Gazizyanova V.M., Bulashova O.V., Khazova E.V., Khasanov N.R., Oslopov V.N. Clinical Variants of Chronic Heart Failure in Combination with Chronic Obstructive Pulmonary Disease. PM. 2019;(2):58–63.
8. Darbinyan V.O., Nemolyaeva E.K. Albuminuria as a Marker of Chronic Kidney Disease and Cardiovascular Comorbidity in Type 2 Diabetes Mellitus. BMIK. 2021;(9):196.
9. Dedov I.I., Shestakova M.V., Galstyan G.R. Prevalence of Type 2 Diabetes Mellitus in the Adult Population of Russia (NATION Study). Diabetes Mellitus. 2016;19(2):104–112.
10. Efremova E.V., Shutov A.M., Petrova E.V. Personality Traits and Adaptation Mechanisms in Patients with Arterial Hypertension and Chronic Heart Failure. The Russian Archives of Internal Medicine. 2021;1(57):34–42.
11. Kokov A.N., Masenko V.L., Kareeva A.I. et al. The Profile of a Patient with Stable Coronary Artery Disease and Impaired Muscle Status. Cardiovascular Therapy and Prevention. 2022;21(12):16–23. doi:10.15829/1728-8800-2022-3454.
12. Safiullina A.A., Uskach T.M., Saipudinova K.M. et al. Heart Failure and Obesity. Therapeutic Archive. 2022;94(9):1115–1121.
13. Albert M.A. Health-Related Quality of Life in Comorbid Heart Failure with Reduced Ejection Fraction and Diabetes Mellitus. Journal of the American College of Cardiology (JACC). 2019;(25):3176–3178.
14. Butterly et al. Medication-Attributable Adverse Events in Heart Failure Trials. Journal of the American College of Cardiology / American College of Cardiology Foundation. 2023;(4):425–436.
15. Chen et al. Heart Failure Diagnosis: Impacts of Atrial Fibrillation on the Diagnostic Marker NT-proBNP. PLOS Medicine. 2025:1–4.
16. China Kadoorie Biobank. Metabolically Healthy Obesity, Transition to Unhealthy Phenotypes, and Type 2 Diabetes in 0.5 Million Chinese Adults. European Journal of Endocrinology. 2022;186:233–244.
17. Pradipta I.S. Characteristics, Knowledge, Attitude, and Practice of Pharmacy Personnel in Supporting Tuberculosis Treatment: A Multicenter Cross-Sectional Study in a High-Burden Tuberculosis Country. Journal of the American Pharmacists Association. 2024;(1):2–4.
18. Agress S., et al. The Interplay of Comorbidities in Chronic Heart Failure: Challenges and Solutions. Current Cardiology Reviews. 2024;20(3):110–119.
19. Tong M., Saito T., Zhai P. et al. Mitophagy Is Essential for Maintaining Cardiac Function During High-Fat Diet-Induced Diabetic Cardiomyopathy. Circulation Research. 2019;124(9):1360–1371. doi:10.1161/CIRCRESAHA.118.314607.
20. Zhang et al. The Influence of Non-Cardiac Comorbidity Burden on Heart Failure with Improved Ejection Fraction: Evaluated by the Charlson Comorbidity Index. Current Medical Research and Opinion. 2025:1149–1163.
